Laddar...
Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.
One of the current goals in vaccine development is the noninvasive administration of protective antigens via mucosal surfaces. In this context, the gut-associated lymphoid tissues have already been extensively explored. Vaccination via the nasal route has only recently been the focus of intensive in...
Sparad:
| Huvudupphovsmän: | , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
1997
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC176094/ https://ncbi.nlm.nih.gov/pubmed/9009311 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|